1-2 of 2
the Austrian Cooperation on MabCampath Use in CLL
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Retreatment with Alemtuzumab after a First, Successful Alemtuzumab Treatment in B-CLL.

Michael Fiegl, Florian Falkner, Andreas Falkner, Niklas Zojer, Michael Fridrik, Georg Hopfinger, Reinhard Stauder, Ebehard Gunsilius, Johanna Kantner, Martin Erdel, Inge Tinhofer, Guenther Gastl, Richard Greil, the Austrian Cooperation on MabCampath Use in CLL
Journal: Blood
Blood (2007) 110 (11): 4714.
https://doi.org/10.1182/blood.V110.11.4714.4714
Published: 2007
Journal Articles

Alemtuzumab in B-Cell Prolymphoytic Leukemia (B-PLL) and Richter’s Transformation.

Michael Fiegl, Andreas Falkner, Michael Fidrik, Gerhard Postner, Alois Lang, Niklas Zojar, Guenther Gastl, Richard Greil, for the Austrian Cooperation on MabCampath Use in CLL
Journal: Blood
Blood (2006) 108 (11): 4733.
https://doi.org/10.1182/blood.V108.11.4733.4733
Published: 2006